BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,687,081 | -33.8% | 177,188 | -20.0% | 0.08% | -29.1% |
| Q2 2023 | $10,094,509 | -1.6% | 221,565 | -12.4% | 0.11% | -6.8% |
| Q1 2023 | $10,260,064 | -37.9% | 252,960 | -22.0% | 0.12% | -40.7% |
| Q4 2022 | $16,529,579 | -40.9% | 324,300 | -37.5% | 0.20% | -43.6% |
| Q3 2022 | $27,963,000 | -16.0% | 519,187 | +0.2% | 0.35% | -11.5% |
| Q2 2022 | $33,287,000 | -16.6% | 518,245 | +0.7% | 0.40% | -0.7% |
| Q1 2022 | $39,889,000 | -10.0% | 514,428 | -0.4% | 0.40% | -2.2% |
| Q4 2021 | $44,334,000 | -4.3% | 516,468 | -10.3% | 0.41% | -11.2% |
| Q3 2021 | $46,325,000 | +0.2% | 575,964 | +0.3% | 0.46% | +1.3% |
| Q2 2021 | $46,231,000 | -5.4% | 574,300 | -0.9% | 0.46% | -10.9% |
| Q1 2021 | $48,873,000 | +1.9% | 579,480 | -3.0% | 0.51% | -3.8% |
| Q4 2020 | $47,940,000 | -1.1% | 597,458 | -0.8% | 0.53% | -11.9% |
| Q3 2020 | $48,451,000 | -5.2% | 602,470 | +1.5% | 0.60% | -9.4% |
| Q2 2020 | $51,122,000 | +4.2% | 593,757 | -1.7% | 0.67% | -6.7% |
| Q1 2020 | $49,050,000 | -3.8% | 604,138 | -0.9% | 0.72% | +23.7% |
| Q4 2019 | $50,979,000 | -4.8% | 609,646 | -0.5% | 0.58% | -10.5% |
| Q3 2019 | $53,571,000 | +5.6% | 612,451 | -1.1% | 0.65% | +6.2% |
| Q2 2019 | $50,732,000 | -6.1% | 619,435 | -6.8% | 0.61% | -7.2% |
| Q1 2019 | $54,055,000 | +12.9% | 664,797 | -8.6% | 0.66% | +1.5% |
| Q4 2018 | $47,871,000 | -14.9% | 727,309 | -0.3% | 0.65% | -1.4% |
| Q3 2018 | $56,246,000 | +2.6% | 729,609 | -1.7% | 0.66% | -3.7% |
| Q2 2018 | $54,826,000 | +4.2% | 742,496 | -8.2% | 0.68% | +4.8% |
| Q1 2018 | $52,593,000 | -22.5% | 808,632 | -23.0% | 0.65% | -17.5% |
| Q4 2017 | $67,877,000 | -7.3% | 1,050,079 | -10.0% | 0.79% | -10.5% |
| Q3 2017 | $73,198,000 | -17.8% | 1,166,500 | -20.7% | 0.88% | -18.4% |
| Q2 2017 | $89,056,000 | +5.2% | 1,471,022 | -9.9% | 1.08% | +3.9% |
| Q1 2017 | $84,625,000 | +8.9% | 1,631,800 | -6.9% | 1.04% | +3.9% |
| Q4 2016 | $77,707,000 | -14.2% | 1,752,525 | -7.9% | 1.00% | -16.4% |
| Q3 2016 | $90,616,000 | +2.8% | 1,903,688 | -2.3% | 1.19% | +0.4% |
| Q2 2016 | $88,111,000 | +5.4% | 1,948,504 | -4.3% | 1.19% | 0.0% |
| Q1 2016 | $83,635,000 | -2.7% | 2,035,912 | -9.6% | 1.19% | -7.7% |
| Q4 2015 | $85,942,000 | +13.8% | 2,252,752 | -2.0% | 1.29% | +9.2% |
| Q3 2015 | $75,501,000 | -53.7% | 2,298,348 | -1.5% | 1.18% | -48.9% |
| Q2 2015 | $163,166,000 | +2.0% | 2,333,273 | -0.1% | 2.31% | +5.0% |
| Q1 2015 | $159,999,000 | -6.2% | 2,335,756 | +0.4% | 2.20% | -7.0% |
| Q4 2014 | $170,487,000 | +1.7% | 2,326,203 | -0.4% | 2.37% | -3.3% |
| Q3 2014 | $167,700,000 | -1.0% | 2,336,628 | -0.3% | 2.45% | +1.9% |
| Q2 2014 | $169,391,000 | -1.7% | 2,342,897 | +0.0% | 2.40% | -6.0% |
| Q1 2014 | $172,344,000 | +15.0% | 2,342,265 | +8.7% | 2.55% | +10.8% |
| Q4 2013 | $149,926,000 | +30.1% | 2,155,658 | +22.9% | 2.31% | +15.8% |
| Q3 2013 | $115,229,000 | -5.9% | 1,754,137 | -0.8% | 1.99% | -15.0% |
| Q2 2013 | $122,505,000 | – | 1,768,515 | – | 2.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |